MRSA strains with distinct accessory genes predominate at different ages in cystic fibrosis

Harry S Porterfield1,2, Lucas J Maakestad3, Mason M LaMarche3

  • 1Department of Pathology, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA.

Abstract

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) subtypes in cystic fibrosis (CF) patients show distinct genomic features and age prevalence. Certain MRSA strains, like ST5 and ST105, are linked to reduced lung function in younger CF patients.

Area of Science:

  • Microbiology
  • Genomics
  • Infectious Diseases

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) is a significant pathogen in cystic fibrosis (CF) patients.
  • Whole genome sequencing (WGS) offers potential to identify MRSA genomic variations linked to clinical outcomes and transmission dynamics.

Purpose of the Study:

  • To identify specific MRSA genes associated with diminished lung function in CF.
  • To investigate potential MRSA transmission patterns within CF populations using genomic analysis.

Main Methods:

  • Collected 97 MRSA isolates from 74 individuals with CF.
  • Performed short-read whole genome sequencing (WGS) to determine sequence types (ST) and phylogenetic relationships.
  • Analyzed accessory gene content and correlated it with clinical outcomes, including lung function (FEV1).

Main Results:

  • The most common MRSA sequence types (ST) were ST5, ST8, and ST105.
  • MRSA strains were frequently shared among family members with CF but rarely between unrelated individuals.
  • Three distinct MRSA clusters (A, B, C) were identified based on accessory gene content.
  • Cluster A (ST5, ST105) was prevalent across all ages and associated with lower FEV1 in patients ≤20 years old.
  • Cluster B (ST8) was more prevalent in younger patients.

Conclusions:

  • MRSA exhibits distinct subtypes in CF patients, varying by age and accessory gene composition.
  • A prevalent MRSA cluster (ST5, ST105) is associated with reduced lung function (FEV1) in younger CF individuals.
  • The increasing prevalence of ST8 MRSA in younger patients suggests a potential future shift in dominant MRSA strains within the CF population.